Oakworth Capital Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 15.5% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,458 shares of the healthcare conglomerate’s stock after selling 633 shares during the quarter. Oakworth Capital Inc.’s holdings in UnitedHealth Group were worth $ 1,764,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Lincoln National Corp lifted its position in shares of UnitedHealth Group by 15.1% during the 4th quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock valued at $ 4,495,000 after acquiring an additional 1,174 shares during the last quarter. YorkBridge Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 1.8% during the 4th quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock valued at $ 7,681,000 after acquiring an additional 272 shares during the last quarter. Alexandria Capital LLC lifted its position in shares of UnitedHealth Group by 3.5% during the 3rd quarter. Alexandria Capital LLC now owns 17,100 shares of the healthcare conglomerate’s stock valued at $ 6,682,000 after acquiring an additional 584 shares during the last quarter. BOKF NA lifted its position in shares of UnitedHealth Group by 3.0% during the 4th quarter. BOKF NA now owns 87,046 shares of the healthcare conglomerate’s stock valued at $ 43,709,000 after acquiring an additional 2,546 shares during the last quarter. Finally, First International Bank & Trust acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at $ 426,000. 87.48% of the stock is owned by hedge funds and other institutional investors.
A number of research firms have recently issued reports on UNH. Loop Capital began coverage on UnitedHealth Group in a report on Thursday, June 16th. They issued a “buy” rating and a $ 575.00 target price for the company. Barclays increased their target price on UnitedHealth Group from $ 495.00 to $ 565.00 and gave the company an “overweight” rating in a report on Wednesday, March 30th. Truist Financial increased their target price on UnitedHealth Group from $ 575.00 to $ 610.00 in a report on Thursday, April 7th. Royal Bank of Canada set a $ 563.00 price target on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research note on Monday, April 18th. Finally, Credit Suisse Group upped their price target on shares of UnitedHealth Group from $ 564.00 to $ 595.00 and gave the stock an “outperform” rating in a research note on Monday, April 18th. Three investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $ 555.73.
Shares of NYSE: UNH opened at $ 480.32 on Wednesday. The company has a market cap of $ 450.62 billion, a P / E ratio of 26.29, a P / E / G ratio of 1.41 and a beta of 0.83. The stock’s 50-day moving average is $ 497.50 and its 200-day moving average is $ 490.87. UnitedHealth Group Incorporated has a 52-week low of $ 383.12 and a 52-week high of $ 553.29. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78.
UnitedHealth Group (NYSE: UNH – Get Rating) last issued its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $ 5.40 by $ 0.09. The company had revenue of $ 80.15 billion for the quarter, compared to the consensus estimate of $ 78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The firm’s revenue was up 14.2% compared to the same quarter last year. During the same period last year, the business posted $ 5.31 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be paid a $ 1.65 dividend. This represents a $ 6.60 annualized dividend and a dividend yield of 1.37%. The ex-dividend date is Thursday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $ 1.45. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.12%.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $ 493.25, for a total transaction of $ 1,233,125.00. Following the completion of the transaction, the director now owns 1,220,000 shares in the company, valued at $ 601,765,000. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Frederick William Mcnabb III purchased 89 shares of the business’s stock in a transaction on Thursday, May 26th. The shares were acquired at an average price of $ 504.32 per share, with a total value of $ 44,884.48. Following the purchase, the director now owns 11,259 shares of the company stock, valued at $ 5,678,138.88. The disclosure for this purchase can be found here. In the last quarter, insiders sold 8,000 shares of company stock valued at $ 3,956,925. 0.40% of the stock is owned by corporate insiders.
About UnitedHealth Group: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE: UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.